Bock HL - Search Results

1

Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix()).

Zhu F, Zhang S, Hou Q, Zhang Y, Xu Y, Ma X, Lu X, Pan H, Chen D, Ramakrishnan G, Zhao R, Tang H, Van Der Meeren O, Bock HL. Zhu F, et al. Among authors: bock hl. Hum Vaccin. 2010 Mar 3;6(3):10503. doi: 10.4161/hv.6.3.10503. Epub 2010 Mar 3. Hum Vaccin. 2010. PMID: 20215881

2

Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine.

Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Tang H, Hoet B, Bock HL. Lin TY, et al. Among authors: bock hl. Hum Vaccin. 2008 Jan-Feb;4(1):50-3. doi: 10.4161/hv.4.1.4935. Epub 2007 Aug 27. Hum Vaccin. 2008. PMID: 18376147

3

Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.

Gatchalian SR, Ramakrishnan G, Bock HL, Lefevre I, Jacquet JM. Gatchalian SR, et al. Among authors: bock hl. Hum Vaccin. 2010 Aug;6(8):664-72. doi: 10.4161/hv.6.8.12155. Hum Vaccin. 2010. PMID: 20657177 Clinical Trial.

4

Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents.

Huang LM, Chang LY, Tang H, Bock HL, Lu CY, Huang FY, Lin TY, Lee CY. Huang LM, et al. Among authors: bock hl. J Adolesc Health. 2005 Dec;37(6):517. doi: 10.1016/j.jadohealth.2005.08.009. J Adolesc Health. 2005. PMID: 16310132 Clinical Trial.

5

Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age.

Lin TY, Wang YH, Chang LY, Chiu CH, Huang YC, Tang H, Bock HL. Lin TY, et al. Among authors: bock hl. Chang Gung Med J. 2003 May;26(5):315-22. Chang Gung Med J. 2003. PMID: 12934847 Free article.

6

Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting.

Lim FS, Phua KB, Lee BW, Quak SH, Teoh YL, Ramakrishnan G, Han HH, Van Der Meeren O, Jacquets JM, Bock HL. Lim FS, et al. Among authors: bock hl. Southeast Asian J Trop Med Public Health. 2011 Jan;42(1):138-47. Southeast Asian J Trop Med Public Health. 2011. PMID: 21323176 Clinical Trial.

7

A hospital-based surveillance of rotavirus gastroenteritis in children <5 years of age in Singapore.

Phua KB, Tee N, Tan N, Ramakrishnan G, Teoh YL, Bock H, Liu Y. Phua KB, et al. Pediatr Infect Dis J. 2013 Dec;32(12):e426-31. doi: 10.1097/INF.0b013e31829f2cb0. Pediatr Infect Dis J. 2013. PMID: 23958814

8

A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children.

Lee CY, Tang RB, Huang FY, Tang H, Huang LM, Bock HL. Lee CY, et al. Among authors: bock hl. Int J Infect Dis. 2002 Sep;6(3):202-9. doi: 10.1016/s1201-9712(02)90112-8. Int J Infect Dis. 2002. PMID: 12718836 Free article. Clinical Trial.

9

Immunogenicity of a live-attenuated human rotavirus RIX4414 vaccine with or without buffering agent.

Kerdpanich A, Chokephaibulkit K, Watanaveeradej V, Vanprapar N, Simasathien S, Phavichitr N, Bock HL, Damaso S, Hutagalung Y, Han HH. Kerdpanich A, et al. Among authors: bock hl. Hum Vaccin. 2010 Mar 26;6(3):10428. doi: 10.4161/hv.6.3.10428. Epub 2010 Mar 26. Hum Vaccin. 2010. PMID: 20220306

10

Immunogenicity of a human rotavirus vaccine (RIX4414) after storage at 37 °C for seven days.

Kerdpanich A, Chokephaibulkit K, Watanaveeradej V, Vanprapar N, Simasathien S, Phavichitr N, Bock HL, Damaso S, Hutagalung Y, Han HH. Kerdpanich A, et al. Among authors: bock hl. Hum Vaccin. 2011 Jan 1;7(1):74-80. doi: 10.4161/hv.7.1.13412. Epub 2011 Jan 1. Hum Vaccin. 2011. PMID: 21228629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page